Opdivo gets FDA approval for use around lung cancer surgery, following Keytruda and Imfinzi
The FDA has given the green light to Bristol Myers Squibb’s Opdivo for use before and after surgery for non-small cell lung cancer.
A regimen …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
